Department of Obstetrics and Gynecology, International Islamic Center for Population Studies and Research, Al Azhar University, Cairo, Egypt.
Int J Gynaecol Obstet. 2010 May;109(2):93-6. doi: 10.1016/j.ijgo.2010.01.001. Epub 2010 Feb 6.
Reinfibulation is resuturing after delivery or gynecological procedures of the incised scar tissue resulting from infibulation. Despite the global fight against female genital mutilation/cutting (FGM/C), reinfibulation of previously mutilated or circumcised women is still performed in various countries around the world. A good estimate of the prevalence of reinfibulation is difficult to obtain, but it can be inferred that 6.5-10.4million women are likely to have been reinfibulated worldwide. Women who undergo reinfibulation have little influence on the decision-making and are usually persuaded by the midwife or birth attendant to undergo the procedure immediately following labor or gynecological operation. Although medicalization of reinfibulation may reduce its immediate risks, it has no effect on the incidence of long-term risks. Reinfibulation is performed mainly for the financial benefit of the operator, and cultural values that have been perpetuated for generations. Reinfibulation has no benefits and is associated with complications for the woman and the unborn child. Its medicalization violates the medical code of ethics and should be abandoned. International and national efforts should be combined to eradicate this practice.
再缝合是指在分娩或妇科手术后，对因阴部切割而形成的切口疤痕组织进行重新缝合。尽管全球都在打击女性生殖器官切割，但在世界各地的许多国家，仍有为以前受过切割或割礼的女性进行再缝合的行为。要准确估计再缝合的流行程度是很困难的，但可以推断，全世界可能有 650 万至 1040 万妇女接受了再缝合。接受再缝合的妇女在决策方面几乎没有影响力，通常会在分娩或妇科手术后立即被助产士或接生员说服接受该手术。尽管再缝合的医学化可能会降低其直接风险，但对长期风险的发生率没有影响。再缝合主要是为了操作者的经济利益，以及几代人延续下来的文化价值观。再缝合对妇女和未出生的孩子都没有好处，反而会带来并发症。它的医学化违反了医学伦理准则，应该被摒弃。应该结合国际和国家的努力来根除这种做法。
